Nathan J. Schauer - Concepedia

Author

Nathan J. Schauer

Harvard University ORCID

Also Known As

Nathan J Schauer, Nathan J. Schauer, Nathan Schauer

Publications

Citations

H-Index

Concepts

All Affiliations

Harvard University Dana-Farber Cancer Institute Broad Institute Boston Children's Hospital Brigham and Women's Hospital

About

Nathan J. Schauer is an author at Harvard University specializing in natural sciences, medicine, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	5	5	518
2	Medicine	4	4	520
3	Biochemistry	3	3	414
4	Cell Biology	3	3	335
5	Chemical Biology	2	2	224

Nathan J. Schauer

Publications

846

Citations

H-Index

Page 1

	Year	Citations
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion Isaac S. Harris, Jennifer E. Endress, Jonathan L. Coloff, Cell Metabolism Reductive StressBiochemistryMedicineGlutathione DepletionCancer Cells	2019	190
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7 Ilaria Lamberto, Xiaoxi Liu, Hyuk‐Soo Seo, Cell chemical biology Medicinal ChemistryDrug TargetBiochemistryNatural SciencesMedicine	2017	185
Inhibition of USP10 induces degradation of oncogenic FLT3 Ellen Weisberg, Nathan J. Schauer, Jing Yang, Nature Chemical Biology Oncogenic AgentNatural SciencesMolecular BiologyExperimental ToxicologyGene Expression	2017	149
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism Nathan J. Schauer, Xiaoxi Liu, Robert S. Magin, Scientific Reports Selective Usp7 InhibitionApoptosisCell DeathMolecular BiologyCancer Biology	2020	115
Accelerating inhibitor discovery for deubiquitinating enzymes Wai Cheung Chan, Xiaoxi Liu, Robert S. Magin, Nature Communications	2023	75
Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in <i>TP53</i> wild-type Ewing sarcoma Björn Stolte, Amanda Balboni Iniguez, Neekesh V. Dharia, The Journal of Experimental Medicine	2018	63
Proteomics-Based Identification of DUB Substrates Using Selective Inhibitors Jonathan W. Bushman, Katherine A. Donovan, Nathan J. Schauer, Cell chemical biology Proteomic TechnologyBiochemistryNatural SciencesProteomics-based IdentificationProtein Engineering	2020	39
Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2 Jing Yang, Ellen Weisberg, Xiaoxi Liu, Leukemia Hematological MalignancyNovel TherapyNatural SciencesReceptor Tyrosine KinaseMalignant Blood Disorder	2021	30

Page 1